<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-ijms-21-08230">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cagel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grotz</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bernabeu</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Moretton</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Chiappetta</surname>
    <given-names>D.A.</given-names>
   </name>
  </person-group>
  <article-title>Doxorubicin: Nanotechnological overviews from bench to bedside</article-title>
  <source>Drug Discov. Today</source>
  <year>2017</year>
  <volume>22</volume>
  <fpage>270</fpage>
  <lpage>281</lpage>
  <pub-id pub-id-type="doi">10.1016/j.drudis.2016.11.005</pub-id>
  <pub-id pub-id-type="pmid">27890669</pub-id>
 </element-citation>
</ref>
